• Featured Product
  • KD/KO Validated

LATS2-Specific Polyclonal antibody

LATS2-Specific Polyclonal Antibody for FC, IF, IHC, IP, WB,ELISA

Host / Isotype

Rabbit / IgG


human, mouse





Cat no : 20276-1-AP


KPM, LATS2, Warts like kinase

Tested Applications

Positive WB detected inSGC-7901 cells, mouse brain tissue, human heart tissue
Positive IP detected inHEK-293 cells
Positive IHC detected inhuman liver cancer tissue, human colon tissue, mouse skeletal muscle tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF detected inHepG2 cells
Positive FC detected inHeLa cells

Recommended dilution

Western Blot (WB)WB : 1:500-1:2000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for IP and 1:200-1:1000 for WB
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)IF : 1:20-1:200
Sample-dependent, check data in validation data gallery

Product Information

20276-1-AP targets LATS2-Specific in WB, IP, IHC, IF, FC,ELISA applications and shows reactivity with human, mouse samples.

Tested Reactivity human, mouse
Cited Reactivity human, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Peptide
Full Name LATS, large tumor suppressor, homolog 2 (Drosophila)
Calculated molecular weight 120 kDa
Observed molecular weight 150 kDa
GenBank accession numberNM_014572
Gene symbol LATS2
Gene ID (NCBI) 26524
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

LATS2, also named as KPM, belongs to the protein kinase superfamily and AGC Ser/Thr protein kinase family. LATS2 is a tumor suppressor which plays a critical role in centrosome duplication, maintenance of mitotic fidelity and genomic stability. It negatively regulates G1/S transition by down-regulating cyclin E/CDK2 kinase activity. It is a negative regulator of the androgen receptor. LATS2 has a calculated molecular mass of 120 kDa and an apparent molecular mass of 150 kDa (PMID: 10871863). The antibody is specific to LATS2.


Product Specific Protocols
WB protocol for LATS2-Specific antibody 20276-1-APDownload protocol
IHC protocol for LATS2-Specific antibody 20276-1-APDownload protocol
IF protocol for LATS2-Specific antibody 20276-1-APDownload protocol
IP protocol for LATS2-Specific antibody 20276-1-APDownload protocol
FC protocol for LATS2-Specific antibody 20276-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols




Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP.

Authors - Minjing Li

Oxid Med Cell Longev

miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.

Authors - Tangwei Wu

Cell Death Dis

CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer.

Authors - Site Yu


A comprehensive evaluation of Hippo pathway silencing in sarcomas.

Authors - Nicole M Merritt

JCI Insight

Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling.

Authors - Zhiguo Chen

Cell Rep

The CalcR-PKA-Yap1 Axis Is Critical for Maintaining Quiescence in Muscle Stem Cells.

Authors - Lidan Zhang